Dabur ‘Immunity Vans’ bring Ayurvedic medicines at your Doorstep

▴ Dabur ‘Immunity Vans’ bring Ayurvedic medicines at your Doorstep
These specially designed vans, which is part of Dabur’s direct-to-consumer ‘Immunity at your Doorstep’ initiative, have been deployed across 10 cities in India

Moving forward on its mission to provide Health & Well-Being for every household, India’s leading Ayurvedic products maker Dabur India Ltd has launched ‘Dabur Immunity Vans’, a special initiative aimed at taking its range of Ayurvedic medicines and products closer to consumer households. These specially designed vans, which is part of Dabur’s direct-to-consumer ‘Immunity at your Doorstep’ initiative, have been deployed across 10 cities in India to give consumers access to immunity-boosting products at their doorsteps.

Through these Vans, Dabur is offering a range of immunity boosting products like Dabur Chyawanprash, Dabur Giloy ki Ghanvati tablets, Dabur Ashagandha capsules and ImuDab syrup, to name a few. These products are highly relevant in today's times when consumers are seeking to build their immunity to fight illnesses. In addition, consumers can also purchase Dabur’s recently launched Immunity booster range, which includes products like Dabur Amla juice, Dabur Giloy Ras, Dabur Giloy-Neem-Tulsi juice, Dabur Tulsi Drops, Dabur Haldi Drops etc, from these mobile Ayurvedic outlets.

 “Consumers have been seeking quality Ayurvedic immunity-boosting products in the wake of the rapid spread of the COVID pandemic. With consumers still wary of stepping out and going to markets to purchase these products, we have decided to bring these effective Ayurvedic remedies to their doorstep with our Immunity Van initiative. Through these Specially designed vans, we are not only giving consumers easy access to Ayurvedic products but also educating them about the benefits of Ayurvedic medicines and products in boosting their immunity and fighting illnesses,” Dabur India Ltd Senior General Manager-Marketing Ms Minoo Phakey said.

 In the first phase, Dabur has rolled out 12 Immunity Vans, which have deployed in cities like Lucknow, Kanpur, Varanasi, Indore, Bhopal, Nagpur, Jabalpur, Ludhiana, Bilaspur, Jaipur, Patna and Raipur. These specially designed vans are moving around residential localities and Government Offices, among other places, in these cities.

“Dabur Immunity Van is a unique initiative that combines technology with innovation to minimise crowd gathering. Proper care has been taken to maintain social distancing protocols while giving consumers access to efficacious Ayurvedic products for the daily Health and Wellness needs. Our team of promoters are present in these vans to explain the benefits of the Dabur products and importance of immunity to fight illnesses,” Ms Phakey said.

Tags : #LatestPharmaNewsNov3 #LatestDaburNewsNov3 #DaburImmunityVans #AyurvedicTreatment #ImmunityAtYourDoorStep

Related Stories

14 Feb

Novartis India Limited signs exclusive sales and distribution agreement with Dr. Reddy’s Laboratories

Latest corporate news update; Pharma

View
03 Feb

European Commission approves Teysuno in metastatic colorectal cancer

Latest Corporate news updates; Pharma Feb 3rd 2022

View
24 Dec

Novartis acquires a gene-therapy company Gyroscope Therapeutics

Swiss healthcare giant Novartis has agreed to pay $1.5 billion to acquire British biotech company Gyroscope Therapeutics.

View
31 Aug

ImmixBio and BeiGene to evaluate combination of IMX-110 and Tislelizumab in solid tumors

Latest Pharma News Update

View
02 Aug

GSK and Vir Biotechnology announce joint procurement agreement with European Commission for COVID-19 treatment, Sotrovimab

Latest pharma news update

View
21 Jun

Novartis receives FDA approval 177Lu-PSMA-617 for metastatic castration resistant prostate cancer

FDA breakthrough therapy for Novartis metastatic prostate cancer drug

View
08 May

Roche’s Tecentriq approved by European Commission for metastatic non-small cell lung cancer

Tecentriq is now the first and only single-agent cancer immunotherapy with three dosing options

View
25 Mar

Novartis announces positive result of phase III study with radioligand therapy 177Lu-PSMA-617

The study is aimed for patients with advanced prostate cancer

View
15 Feb

Xeris Pharmaceuticals receives approval from the European Commission for Ogluo

Ogluo (Glucagon) is indicated treatment of severe hypoglycemia

View
10 Feb

Novartis receives FDA Breakthrough Therapy designations for STAMP inhibitor asciminib (ABL001)

Novartis receives FDA Breakthrough Therapy designations for investigational STAMP inhibitor asciminib (ABL001) in chronic myeloid leukaemia

View

-Advertisements-




Trending Now

Maternal and Infant Health in Focus as India Observes World Health Day 2025April 05, 2025
Under 15 Children Under Threat: The TB Comeback No One Saw Coming April 04, 2025
MGM Healthcare Performs World's First Modified Multi-Visceral Transplant for Rare Intestinal DisorderApril 04, 2025
World Health Day 2025: St. George’s University’s Role in Preparing Doctors to Tackle Global Health ChallengesApril 04, 2025
Strength Doesn’t Retire: The Science Behind Ageless PowerApril 04, 2025
Beyond the Baby Bump: Can Delayed Pregnancy Increase Autism Risk in ChildrenApril 04, 2025
University of Manchester invites applications for MA Social AnthropologyApril 03, 2025
Ahead of World Health Day, Sova Health Launches Advanced Microbiome Tests & Evidence-Based Precision Supplements April 03, 2025
Half of women cannot make decisions about their reproductive health and bodily autonomyApril 03, 2025
UGRO CAPITAL LIMITED PUBLIC ISSUE OF SECURED, RATED, LISTED, REDEEMABLE, NON-CONVERTIBLE DEBENTURES (SECURED NCDS) OPENS TODAY EFFECTIVE ANNUALIZED YIELD UP TO 11.01% PER ANNUM* April 03, 2025
SF Airlines Entrusts Çelebi India with Freighter Handling at Kempegowda International Airport, BengaluruApril 03, 2025
Is This the Future of Physiotherapy? Inside Stance Health’s $1M ExpansionApril 03, 2025
The Daily Shower Debate: Are You Washing Away Your Skin’s Health?April 03, 2025
The Digital Sleep Thief: How Night-time Screen Addiction is Robbing You of Bed-time RestApril 02, 2025
KKR Launches ‘Knight Bite’ – A Digital Series That Serves Up Food, Fun, and Cricket!April 02, 2025
Crompton rolls out its all new range of Aura, Avancer & Jedi Air Coolers for an effortless summer cooling experienceApril 02, 2025
CARE Hospitals, Hi-Tech City Strengthens Orthopaedics Department with Renowned SurgeonsApril 02, 2025
World Autism Awareness Day: Breaking the Chains of Stigma in IndiaApril 02, 2025
From Scroll to Squint: How Reels Are Reshaping Your VisionApril 02, 2025
Moscow Center for Diagnostics and Telemedicine Receives License for Radiology Residency ProgramApril 02, 2025